MARKET

XENE

XENE

Xenon Pharmaceut
NASDAQ
39.50
+0.54
+1.39%
After Hours: 38.18 -1.32 -3.34% 16:02 06/05 EDT
OPEN
38.84
PREV CLOSE
38.96
HIGH
39.59
LOW
38.63
VOLUME
315.05K
TURNOVER
0
52 WEEK HIGH
43.57
52 WEEK LOW
26.25
MARKET CAP
2.51B
P/E (TTM)
-16.9805
1D
5D
1M
3M
1Y
5Y
Xenon Pharmaceut: Statement of changes in beneficial ownership of securities
Press release · 3d ago
Xenon Pharmaceut: Current report
Press release · 3d ago
Xenon Pharmaceut: Report of proposed sale of securities
Press release · 3d ago
Analysts Conflicted on These Healthcare Names: MustGrow Biologics (OtherMGROF), CureVac (CVAC) and Xenon (XENE)
TipRanks · 4d ago
Insider Sell: Xenon Pharmaceuticals
Insider Sell: Xenon Pharmaceuticals
MT Newswires · 05/30 00:21
Xenon Pharmaceuticals: Navigating The Neural Network Of Epilepsy And Depression
Seeking Alpha · 05/23 15:26
Jefferies Remains a Buy on Xenon (XENE)
TipRanks · 05/15 13:25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Xenon (XENE), IDEAYA Biosciences (IDYA) and Demant (OtherWILLF)
TipRanks · 05/12 01:50
More
About XENE
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company is focused on advancing its ion channel neurology pipeline. The Company's products within its novel proprietary pipeline include clinical-stage candidates XEN496 and XEN1101, which are focused on treating neurological disorders, with a particular focus on epilepsy. XEN1101 is a differentiated Kv7 potassium channel opener being developed for the treatment of epilepsy and major depressive disorder (MDD). The XEN496 is a Kv7 potassium channel opener, is a pediatric formulation of the active ingredient ezogabine being developed for the treatment of KCNQ2 developmental and epileptic encephalopathy, or KCNQ2-DEE. The Company has promising partnered products within its pipelines, such as NBI-921352 with Neurocrine Biosciences and PCRX301 with Pacira BioSciences.

Webull offers kinds of Xenon Pharmaceuticals Inc stock information, including NASDAQ:XENE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XENE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading XENE stock methods without spending real money on the virtual paper trading platform.